ALDER BIOPHARMACEUTICALS INC
Q1 2019 13F Holders
CUSIP
014339AA3
Type
Debt
Class
NOTE 2.500% 2/0
Num filings
31
Total reported value, excl. options
$270 M
Compare 2019 Q1 to
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2018 Q4
2018 Q3
2018 Q2
2018 Q1
Manager
Report Date
Value ($000)
Principal
Option Type